Cochlear moves closer to FDA approval of hybrid system

Cochlear announced that the FDA advisory panel has voted favorably on a hybrid cochlear implant system.  Hybrid cochlear implants combine the functionality of a cochlear implant with that of a hearing aid.  The hearing aid portion provides additional low-frequency information.  These systems are currently available from both Cochlear and MED-EL in some markets outside of the US.